Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA approved.

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by ...

Robert F. Kennedy Jr., who's nominated to become the next health secretary, asked the federal government to revoke its authorization of all COVID-19 vaccines in May 2021, just as vaccinated Americans ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

At the time of writing, Moderna had not as yet responded to enquiries about its intentions surrounding its Covid-19 vaccine, Spikevax. Join the conversation, on Tuesday 28th January @ 10 am ET - 3 ...

Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight bird flu.